Dr. Gregory A. Masters

Eric Raabe, M.D., Ph.D., is an associate professor of oncology and pathology at Johns Hopkins School of Medicine. Dr. Raabe majored in neural science at Brown University and received his M.D. and Ph.D. from the University of Cincinnati College of Medicine. He completed his pediatric internship and residency at Children’s Hospital of Philadelphia. After spending a year working in Africa as part of the Baylor International Pediatric AIDS Initiative, Dr. Raabe joined Johns Hopkins as a pediatric oncology fellow. Working in the laboratory of Charles Eberhart in Neuropathology, Dr. Raabe established a neural stem cell system to create genetically accurate models of pediatric brain tumors. In collaboration with patients and families, he has also developed multiple pediatric brain tumor cell lines that are some of the key models used for pre-clinical testing. Dr. Raabe sees patients in the pediatric oncology outpatient clinic at Johns Hopkins, with a focus on pediatric brain tumors. Dr. Raabe is also the point person in oncology for retinoblastoma care. He continues his research in the new Smith Building of the Wilmer Eye Institute in the Neuropathology Division, in collaboration with Charles Eberhart. Dr. Raabe is rated as an Elite provider by MediFind in the treatment of Pediatric Low-Grade Glioma (pLGG). His top areas of expertise are Rhabdoid Tumor, Diffuse Midline Glioma H3 K27M-Mutant, Glioma, and Pediatric Low-Grade Glioma (pLGG).

Arati Desai is an Oncologist in Philadelphia, Pennsylvania. Dr. Desai is rated as an Elite provider by MediFind in the treatment of Pediatric Low-Grade Glioma (pLGG). Her top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri. Dr. Desai is currently accepting new patients.

Jon Glass is an Oncologist in Voorhees, New Jersey. Dr. Glass is rated as a Distinguished provider by MediFind in the treatment of Pediatric Low-Grade Glioma (pLGG). His top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Gliosarcoma, Glioblastoma, and Neuroepithelioma. Dr. Glass is currently accepting new patients.